Clinical characteristics of control and hypertensive men with and without gallstones
| Controls | Hypertensives | ||||
|---|---|---|---|---|---|
| GSD | No GSD | GSD | No GSD | ||
| Number of subjects | 17 | 242 | 30 | 231 | |
| Age (range) (years) | 54 (51–57) | 51 (50–51) | 51 (48–53) | 51 (50–51) | |
| BMI (kg/m2) | 28 (26–30) | 26 (26–27) | 30 (28–32) | 29 (29–30) | |
| Fb glucose (mmo/l) | 5.0 (3.94–6.14) | 4.5 (4.4–4.7) | 5.93-150(4.88–6.96) | 5.0 (4.81–5.4) | |
| fS insulin (mU/l) | 12.3 (9.0–15.8) | 13.3 (11.7–14.9) | 24.33-150 (17.5–31.0) | 17.1 (15.6–18.6) | |
| Two hour glucose (mmol/l) | 6.0 (3.41–7.93) | 5.2 (4.96–5.5) | 8.93-150 (7.0–10.7) | 6.3 (5.92–6.7) | |
| Two hour insulin (mmol/l) | 63.9 (42.3–83.7) | 53.6 (47.2–60.0) | 114.23-150 (63.2–166) | 83.0 (73.0–93.1) | |
| Plasma cholesterol (mmol/l) | 5.1 (4.8–5.4) | 5.8 (5.7–5.9) | 5.6 (5.2–6.0) | 5.8 (5.7–5.9) | |
| LDL cholesterol (mmol/l) | 3.2 (2.8–3.6) | 3.8 (3.6–4.0) | 3.4 (3.1–3.7) | 3.6 (3.5–3.7) | |
| HDL cholesterol (mmol/l) | 1.1 (1.0–1.2) | 1.2 (1.1–1.3) | 1.1 (1.0–1.2) | 1.2 (1.1–1.3) | |
| Triglycerides (mmol/l) | 1.6 (1.2–2.0) | 1.6 (1.5–1.7) | 2.4 (1.8–3.0) | 1.9 (1.7–2.1) | |
Results are presented as means (95% confidence interval).
↵3-150 p<0.05 for the difference compared with hypertensive subjects without GSD.